Pharmacentric Limited - Accounts to registrar (filleted) - small 18.2
Pharmacentric Limited - Accounts to registrar (filleted) - small 18.2
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 October 2018 |
| for |
| Pharmacentric Limited |
| Pharmacentric Limited (Registered number: 05964690) |
| Contents of the Financial Statements |
| for the Year Ended 31 October 2018 |
| Page |
| Company Information | 1 |
| Balance Sheet | 2 |
| Notes to the Financial Statements | 4 |
| Pharmacentric Limited |
| Company Information |
| for the Year Ended 31 October 2018 |
| DIRECTOR: |
| REGISTERED OFFICE: |
| REGISTERED NUMBER: |
| ACCOUNTANTS: |
| Chartered Accountants |
| Elthorne Gate |
| 64 High Street |
| Pinner |
| HA5 5QA |
| Pharmacentric Limited (Registered number: 05964690) |
| Balance Sheet |
| 31 October 2018 |
| 31.10.18 | 31.10.17 |
| Notes | £ | £ | £ | £ |
| FIXED ASSETS |
| Intangible assets | 4 |
| Property, plant and equipment | 5 |
| CURRENT ASSETS |
| Inventories |
| Debtors | 6 |
| Cash at bank and in hand |
| CREDITORS |
| Amounts falling due within one year | 7 |
| NET CURRENT (LIABILITIES)/ASSETS | ( |
) |
| TOTAL ASSETS LESS CURRENT LIABILITIES |
| PROVISIONS FOR LIABILITIES |
| NET ASSETS |
| CAPITAL AND RESERVES |
| Called up share capital |
| Retained earnings |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the Company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the Company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the Company. |
| Pharmacentric Limited (Registered number: 05964690) |
| Balance Sheet - continued |
| 31 October 2018 |
| In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered. |
| The financial statements were approved by the director on |
| Pharmacentric Limited (Registered number: 05964690) |
| Notes to the Financial Statements |
| for the Year Ended 31 October 2018 |
| 1. | STATUTORY INFORMATION |
| Pharmacentric Limited is a |
| company's registered number and registered office address can be found on the Company Information |
| page. |
| The presentation currency of the financial statements is the Pound Sterling (£). |
| 2. | ACCOUNTING POLICIES |
| Basis of preparing the financial statements |
| The presentation currency of the financial statements is the Pound Sterling (£) which is rounded to |
| nearest £1. |
| Turnover |
| Turnover represents revenue generated from the dispensing chemist and is recognised at the fair value |
| of the consideration received or receivable for goods and services provided in the normal course of |
| business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes |
| into account trade discount, settlement discounts and volume rebates. |
| Goodwill |
| Positive goodwill is capitalised, classified as an asset on the balance sheet and amortised on a straight |
| line basis over its useful economic life. It is reviewed for impairment at the end of the first full financial |
| year following the acquisition and in other periods if events or changes in circumstances indicate that |
| the carrying value may not be recoverable. |
| Goodwill, being the amount paid in connection with the acquisition of a business in 2008, is being |
| amortised evenly at 15 years in straight line basis. |
| Tangible fixed assets |
| Fixtures and fittings | - |
| Stocks |
| Inventories are valued at the lower of cost and net realisable value, after making due allowance for |
| obsolete and slow moving items. |
| Pharmacentric Limited (Registered number: 05964690) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 October 2018 |
| 2. | ACCOUNTING POLICIES - continued |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, |
| except to the extent that it relates to items recognised in other comprehensive income or directly in |
| equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been |
| enacted or substantively enacted by the balance sheet date. |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at |
| the balance sheet date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods |
| different from those in which they are recognised in financial statements. Deferred tax is measured |
| using tax rates and laws that have been enacted or substantively enacted by the year end and that are |
| expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable |
| that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Foreign currencies |
| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at |
| the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of |
| exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at |
| the operating result. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the |
| company's pension scheme are charged to profit or loss in the period to which they relate. |
| 3. | EMPLOYEES AND DIRECTORS |
| The average number of employees during the year was |
| Pharmacentric Limited (Registered number: 05964690) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 October 2018 |
| 4. | INTANGIBLE FIXED ASSETS |
| Goodwill |
| £ |
| COST |
| At 1 November 2017 |
| and 31 October 2018 |
| AMORTISATION |
| At 1 November 2017 |
| Amortisation for year |
| At 31 October 2018 |
| NET BOOK VALUE |
| At 31 October 2018 |
| At 31 October 2017 |
| 5. | PROPERTY, PLANT AND EQUIPMENT |
| Fixtures |
| and |
| fittings |
| £ |
| COST |
| At 1 November 2017 |
| Additions |
| At 31 October 2018 |
| DEPRECIATION |
| At 1 November 2017 |
| Charge for year |
| At 31 October 2018 |
| NET BOOK VALUE |
| At 31 October 2018 |
| At 31 October 2017 |
| Pharmacentric Limited (Registered number: 05964690) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 October 2018 |
| 6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.10.18 | 31.10.17 |
| £ | £ |
| Trade debtors |
| VAT |
| Deferred tax asset |
| Prepayments and accrued income |
| 7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
| 31.10.18 | 31.10.17 |
| £ | £ |
| Trade creditors |
| Taxation and social security |
| Other creditors |